Literature DB >> 19251407

Coexistent emphysema delays the decrease of vital capacity in idiopathic pulmonary fibrosis.

Takanori Akagi1, Takemasa Matsumoto, Taishi Harada, Makoto Tanaka, Takashige Kuraki, Masaki Fujita, Kentaro Watanabe.   

Abstract

Although previous authors have reported single data point, yearly changes in respiratory function have not been examined in combined pulmonary fibrosis and emphysema (CPFE). To quantify the annual changes in respiratory function of patients with CPFE and to examine the difference in survival between CPFE patients and patients with idiopathic pulmonary fibrosis without emphysema (IPF alone), 26 patients with CPFE and 33 IPF alone patients, whose respiratory function had been monitored for at least a year, were selected. The baseline of vital capacity percent predicted (VC% pred) in CPFE patients was greater than that in IPF-alone patients (86.6+/-24.0% vs. 72.8+/-19.4%, p=0.018). The annual decrease in VC% pred was significantly less in CPFE patients than in IPF-alone patients (-1.2+/-4.8% vs. -8.0+/-7.4%, p<0.001). Baseline ratio of forced expiratory volume in one second to forced vital capacity (FEV(1)/FVC%) in CPFE patients was lower than that in IPF-alone patients (76.6+/-8.5% vs. 85.2+/-6.7%, p<0.001). In the CPFE group, FEV(1)/FVC% tended to decrease with time (-0.5+/-2.2% per year), but, in contrast, it increased in IPF-alone patients (+1.1+/-3.4% per year) (p=0.036). Baseline of diffusing capacity percent predicted (DLco% pred) was significantly lower in CPFE patients than in IPF-alone patients (45.3+/-15.0% vs. 60.7+/-19.8%, p=0.003). The annual decrease in DLco% pred was lower in CPFE patients than in IPF-alone patients (-3.7+/-7.9% vs. -10.7+/-8.8%, p=0.042). There was no significant difference in the survival duration between 26 CPFE and 33 IPF-alone patients according to Kaplan-Meier analysis. Ventilatory and gas-exchange deterioration during the course of IPF became mild when emphysema was coexistent.

Entities:  

Mesh:

Year:  2009        PMID: 19251407     DOI: 10.1016/j.rmed.2009.02.001

Source DB:  PubMed          Journal:  Respir Med        ISSN: 0954-6111            Impact factor:   3.415


  36 in total

1.  Prognostic value of forced expiratory volume in 1 second/forced vital capacity in idiopathic pulmonary fibrosis.

Authors:  Osamu Nishiyama; Ryo Yamazaki; Akiko Sano; Toshiyuki Yamagata; Hiroyuki Sano; Takashi Iwanaga; Yuji Higashimoto; Hiroaki Kume; Yuji Tohda
Journal:  Chron Respir Dis       Date:  2015-09-15       Impact factor: 2.444

2.  Visually stratified CT honeycombing as a survival predictor in combined pulmonary fibrosis and emphysema.

Authors:  Yong Seek Kim; Gong Yong Jin; Kum Ju Chae; Young Min Han; Su Bin Chon; Young Sun Lee; Keun Sang Kwon; Hye Mi Choi
Journal:  Br J Radiol       Date:  2015-09-21       Impact factor: 3.039

3.  Outcomes of lung cancer resection for patients with combined pulmonary fibrosis and emphysema.

Authors:  Mariko Fukui; Kenji Suzuki; Takeshi Matsunaga; Shiaki Oh; Kazuya Takamochi
Journal:  Surg Today       Date:  2015-08-15       Impact factor: 2.549

4.  Surgical Outcomes of Lung Cancer Patients with Combined Pulmonary Fibrosis and Emphysema and Those with Idiopathic Pulmonary Fibrosis without Emphysema.

Authors:  Seijiro Sato; Terumoto Koike; Takehisa Hashimoto; Hiroyuki Ishikawa; Akira Okada; Takehiro Watanabe; Masanori Tsuchida
Journal:  Ann Thorac Cardiovasc Surg       Date:  2016-04-05       Impact factor: 1.520

5.  An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management.

Authors:  Ganesh Raghu; Harold R Collard; Jim J Egan; Fernando J Martinez; Juergen Behr; Kevin K Brown; Thomas V Colby; Jean-François Cordier; Kevin R Flaherty; Joseph A Lasky; David A Lynch; Jay H Ryu; Jeffrey J Swigris; Athol U Wells; Julio Ancochea; Demosthenes Bouros; Carlos Carvalho; Ulrich Costabel; Masahito Ebina; David M Hansell; Takeshi Johkoh; Dong Soon Kim; Talmadge E King; Yasuhiro Kondoh; Jeffrey Myers; Nestor L Müller; Andrew G Nicholson; Luca Richeldi; Moisés Selman; Rosalind F Dudden; Barbara S Griss; Shandra L Protzko; Holger J Schünemann
Journal:  Am J Respir Crit Care Med       Date:  2011-03-15       Impact factor: 21.405

6.  Prevalence and progression of combined pulmonary fibrosis and emphysema in asymptomatic smokers: A case-control study.

Authors:  Kum Ju Chae; Gong Yong Jin; Young Min Han; Yong Seek Kim; Su Bin Chon; Young Sun Lee; Keun Sang Kwon; Hye Mi Choi; David Lynch
Journal:  Eur Radiol       Date:  2015-02-14       Impact factor: 5.315

Review 7.  Combined pulmonary fibrosis and emphysema (CPFE): an entity different from emphysema or pulmonary fibrosis alone.

Authors:  Huijin Lin; Shanping Jiang
Journal:  J Thorac Dis       Date:  2015-04       Impact factor: 2.895

Review 8.  Combined pulmonary fibrosis and emphysema syndrome: a review.

Authors:  Matthew D Jankowich; Sharon I S Rounds
Journal:  Chest       Date:  2012-01       Impact factor: 9.410

Review 9.  Combined pulmonary fibrosis and emphysema (CPFE): what radiologist should know.

Authors:  Federica Ciccarese; Domenico Attinà; Maurizio Zompatori
Journal:  Radiol Med       Date:  2016-02-19       Impact factor: 3.469

10.  Clinical features and outcomes of patients with lung cancer as well as combined pulmonary fibrosis and emphysema.

Authors:  Hajime Otsuka; Keishi Sugino; Yoshinobu Hata; Takashi Makino; Satoshi Koezuka; Kazutoshi Isobe; Naobumi Tochigi; Kazutoshi Shibuya; Sakae Homma; Akira Iyoda
Journal:  Mol Clin Oncol       Date:  2016-07-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.